Revisions were made on March 7, 2020, to reflect the following:

  • Characteristics of patients with confirmed COVID-19 based on recent epidemiologic data from China, including characteristics of patients with COVID-19 admitted to the intensive care unit and data on pediatric cases
  • Data regarding SARS-CoV-2 viral shedding among asymptomatic persons, and data from a recent report of viable SARS-CoV-2 isolation from stool
  • Accessibility of investigational drug therapies for COVID-19 treatment through clinical trial enrollment in the United States
  • Recently published pediatric surviving sepsis guidance

Updated March 7, 2020

This interim guidance is for clinicians caring for patients with confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease (COVID-19).

Find the full note HERE!